NCT04990466View on ClinicalTrials.gov

Phase 2b/3 Trial of VSV-ΔG SARS-CoV-2 Vaccine (BRILIFE) Against Approved Comparator Vaccine.

PHASE2/PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

September 30, 2021

Primary Completion Date

December 31, 2021

Study Completion Date

February 28, 2022

Conditions
COVID-19
Interventions
DRUG

IIBR-100

Administration of IIBR-100 vaccine

DRUG

Active Comparator

Administration of a currently-approved vaccine for COVID-19

Sponsors

Lead Sponsor

NeuroRx, Inc.
All Listed Sponsors
lead

NeuroRx, Inc.

INDUSTRY